A novel adjunct for COPD: Could it be type II inflammation?

The authors investigate whether type II inflammation, typically associated with eosinophilia, plays a significant role in chronic obstructive pulmonary disease (COPD), which has traditionally been linked to neutrophilia. They highlight the limitations of current COPD management strategies and discuss the recent approval of biologic therapies targeting eosinophilic phenotypes, suggesting a potential shift in treatment approaches for certain patients.